October 20, 2017 4:01 AM ET

Healthcare Providers and Services

Company Overview of Henry Schein, Inc.

Executive Profile

Joseph L. Herring

Independent Director, Henry Schein, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Member in 1 organization across 5 different industries.

See Board Relationships
61$230,010

Background

Mr. Joseph L. Herring, also known as Joe, served as the Chief Executive Officer of Covance Drug Development at Laboratory Corp. of America Holdings from February 2, 2015 to July 31, 2015. Mr. Herring has more than 35 years of experience in the healthcare industry. Mr. Herring served as the Chairman of Covance Inc. from January 1, 2005 to July 2015 and served as its Chief Executive Officer from January 1, 2005 to 2015. He served as the President and Chief Operating Officer ...

Corporate Headquarters

135 Duryea Road
Melville, New York 11747

United States

Phone: 631-843-5500
Fax: 631-843-5652

Board Members Memberships

2016-Present
Independent Director

Education

BSBA 1978
Louisiana State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$44,610
Total Calculated Compensation$230,010
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Mark A. Thierer Interim Chief Executive Officer
DENTSPLY SIRONA Inc.
--
Jonathan W. Ayers Chairman, President & CEO
IDEXX Laboratories, Inc.
$800.0K
Robert S. Weiss Chief Executive Officer, President and Non-Independent Director
The Cooper Companies, Inc.
$1.2M
Thomas E. Richards Chairman, President & CEO
CDW Corporation
$888.5K
Michael J. Farrell BE, SM, MBACEO & Director
ResMed Inc.
$890.2K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Henry Schein, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.